Cardiac and Renal Biomarkers in Arthroplasty Surgery
- Conditions
- Renal InjuryMyocardial InjuryArthropathy of KneeArthropathy of HipAnesthesia
- Interventions
- Drug: Spinal AnesthesiaDrug: General Anesthetics
- Registration Number
- NCT03940651
- Lead Sponsor
- Washington University School of Medicine
- Brief Summary
The investigators will compare the effect of spinal anesthesia to general anesthesia on the level of high sensitivity cardiac biomarkers in patients undergoing hip or knee arthroplasty. The investigators will also measure renal biomarkers in urine to evaluate kidney injury in the postoperative period.
- Detailed Description
The study will enroll a total of 140 adult patients undergoing hip or knee arthroplasty (equal numbers) at Barnes-Jewish-Hospital. These procedures will be randomized with 50% of the procedures performed under spinal anesthesia and 50% procedures performed under general anesthesia.
Patients randomized to spinal anesthesia will receive sedation with dexmedetomidine up to 1 mcg/kg/min, and then add small dose of propofol (up to 50 mcg/kg/min) and fentanyl at the discretion of the anesthesia provider the Richmond Agitation and Sedation Scale (RASS) -2 to -3. Headphones to play music will be offered to patients undergoing spinal anesthesia to minimize the noise generated from the surgical intervention.
The investigators will study the effect of spinal anesthesia versus general anesthesia on cardiac biomarker levels in hip and knee arthroplasty population (levels of Hs-cTnI postoperatively compared to baseline values) Also, the incidence of postoperative renal injury using investigational renal biomarkers, Myo-Inositol Oxygenase (MIOX) and Nephrocheck
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 1
- Adult patients, age 60 years or older
- Ability to provide informed consent
- American Society of Anesthesiologists (ASA) classification II or higher
- Hip fracture procedures
- Contraindications to neuraxial anesthesia per The American Society of Regional Anesthesia (ASRA) guidelines
- Procedure anticipated duration is longer than expected planned spinal anesthesia duration
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Hip Arthroplasty General Anesthetics Surgery to replace the hip joint with prothetic joint Hip Arthroplasty Spinal Anesthesia Surgery to replace the hip joint with prothetic joint Knee Arthroplasty Spinal Anesthesia Surgery to replace the knee joint with prothetic joint Knee Arthroplasty General Anesthetics Surgery to replace the knee joint with prothetic joint
- Primary Outcome Measures
Name Time Method Investigate the effect of general anesthesia on biomarker levels in knee arthroplasty population at time of postoperative visit (around 2 weeks post discharge) cardiovascular effect measured by changes in levels of Hs-cTnI postoperatively compared to baseline values
Incidence of myocardial injury defined by new Hs-cTnI elevation postoperatively at time of postoperative visit (around 2 weeks post discharge) Hs-cTnI increase \>50% above the sex-specific 99th percentile upper reference limit
Investigate the effect of general anesthesia on biomarker levels in hip arthroplasty population at time of postoperative visit (around 2 weeks post discharge) cardiovascular effect measured by changes in levels of Hs-cTnI postoperatively compared to baseline values
Incidence of postoperative renal injury using investigational renal biomarkers at time of postoperative visit (around 2 weeks post discharge) MIOX, Kidney Injury Molecule-1 (KIM-1), Neutrophil gelatinase-associated lipocalin (NGAL) and Nephrocheck measured in ng/ml
Investigate the effect of spinal anesthesia on biomarker levels in hip arthroplasty population at time of postoperative visit (around 2 weeks post discharge) cardiovascular effect measured by changes in levels of Hs-cTnI postoperatively compared to baseline values
Investigate the effect of spinal anesthesia on biomarker levels in knee arthroplasty population at time of postoperative visit (around 2 weeks post discharge) cardiovascular effect measured by changes in levels of Hs-cTnI postoperatively compared to baseline values
- Secondary Outcome Measures
Name Time Method Difference renal biomarkers levels according to anesthesia groups - Pain scores and the incidence of intraoperative hypotension at time of postoperative visit (around 2 weeks post discharge) Pain score assessment using the visual analog score
Difference renal biomarkers levels according to anesthesia groups - Pain medication consumption and the incidence of intraoperative hypotension at time of postoperative visit (around 2 weeks post discharge) Pain medication consumption measured in mg
Difference in cardiac biomarker levels according to surgical groups - Pain scores, pain medications consumption and the incidence of intraoperative hypotension before discharge Pain score assessment using the visual analog score
The effect of nonsteroidal anti-inflammatory drugs (NSAIDs) on renal biomarkers - Pain medication consumption and the incidence of intraoperative hypotension at time of postoperative visit (around 2 weeks post discharge) Pain medication consumption measured in mg
Difference in cardiac biomarker levels according to surgical groups - Pain scores and the incidence of intraoperative hypotension at time of postoperative visit (around 2 weeks post discharge) Pain score assessment using the visual analog score
Difference in renal biomarker levels according to surgical groups - Pain medication consumption and the incidence of intraoperative hypotension at time of postoperative visit (around 2 weeks post discharge) Pain medication consumption measured in mg
The effect of nonsteroidal anti-inflammatory drugs (NSAIDs) on renal biomarkers - Pain scores and the incidence of intraoperative hypotension at time of postoperative visit (around 2 weeks post discharge) Pain score assessment using the visual analog score
Trial Locations
- Locations (1)
Washington University
🇺🇸Saint Louis, Missouri, United States